Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance.
Saved in:
| Title: | Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance. |
|---|---|
| Authors: | Mariottini A; Department of Neurosciences, Drug and Child Health, University of Florence, Viale Gaetano Pieraccini, 6, 50139, Florence, FI, Italy.; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy., Repice AM; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy., Barilaro A; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy., Massacesi L; Department of Neurosciences, Drug and Child Health, University of Florence, Viale Gaetano Pieraccini, 6, 50139, Florence, FI, Italy. luca.massacesi@unifi.it.; Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy. luca.massacesi@unifi.it. |
| Source: | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Jul; Vol. 43 (7), pp. 4095-4097. Date of Electronic Publication: 2022 Mar 23. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1590-3478 (Electronic) Linking ISSN: 15901874 NLM ISO Abbreviation: Neurol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1590-3478 |
|---|---|
| DOI: | 10.1007/s10072-022-05961-9 |
